“… [3] Levobupivacaine is a high-potency, long-acting local anesthetic with a moderately slow onset of action. [4] Levobupivacaine has less attraction for cardiac sodium channels and better plasma protein-binding affinity than the dextranomer, which decreases the risk of cardiotoxicity. Plain levobupivacaine is isobaric concerning cerebrospinal fluid, resulting in the more predictable spread of the drug and thus reducing the incidence of hypotension and bradycardia.…”